Rexahn Pharmaceuticals Inc. (RNN) News Nov 14, 2014, 5:36

New Post Public Reply Private Reply Replies (0) Message Board
Savant
Rexahn Pharmaceuticals Inc. (RNN) News Nov 14, 2014, 5:36 p.m.
MarketWatch News on RNN
Rexahn prices offering at 30% discount 10:58 a.m. Nov. 29, 2012 - MarketWatch.com
AEterna falls; Inspire, Rexahn rally 2:15 p.m. April 16, 2010 - Val Brickates Kennedy
Javelin rockets, Myriad gains on scrapped merger 12:20 p.m. April 12, 2010 - Val Brickates Kennedy
Wednesday's biggest gaining and declining stocks 3:26 p.m. April 7, 2010 - MarketWatch
Rexahn, Avanir gain; Sequenom falls 12:32 p.m. April 7, 2010 - Val Brickates Kennedy
Letter up 230% last year without trading 3:00 a.m. Jan. 11, 2010 - Peter Brimelow
Advertisement
Other News on RNN
10-Q: REXAHN PHARMACEUTICALS, INC. 4:35 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn's New Nanotechnology Patent Creates Next-Generation Docetaxel, Gemcitabine And Cisplatin 9:01 a.m. Oct. 7, 2014 - Seeking Alpha
Rexahn Pharmaceuticals (RNN) Jumps: Stock Gains 10.2% - Tale of the Tape 8:25 a.m. Sept. 26, 2014 - Zacks.com
Rexahn Update: A Partnership Is All The More Likely 12:13 p.m. Sept. 25, 2014 - Seeking Alpha
Rexahn +7.9% AH after RX-3117 receives orphan status 4:55 p.m. Sept. 24, 2014 - Seeking Alpha
Rexahn Pharmaceuticals (RNN) Jumps: Stock Rises 9.6% - Tale of the Tape 8:39 a.m. Sept. 4, 2014 - Zacks.com
Rexahn receives NOA for drug delivery platform patent 12:40 p.m. Sept. 3, 2014 - Seeking Alpha
Update: Rexahn Q2 Earnings - Stock Down, But My Optimism Remains Intact 12:14 a.m. Aug. 15, 2014 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 6:39 a.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn provides update on Supinoxin trial 8:30 a.m. July 18, 2014 - Seeking Alpha
What Falling Estimates & Price Mean for Rexahn Pharmaceuticals (RNN) - Tale of the Tape 7:45 a.m. June 16, 2014 - Zacks.com
Rexahn Pharmaceuticals (RNN) Jumps: Stock Surges 19.2% - Tale of the Tape 8:46 a.m. May 16, 2014 - Zacks.com
More on Rexahn Q1 results and pipeline update 10:42 a.m. May 15, 2014 - Seeking Alpha
10-Q: REXAHN PHARMACEUTICALS, INC. 4:10 p.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Rexahn Pharmaceuticals: An Undervalued Oncology Play With Risk Diversification 4:07 p.m. May 14, 2014 - Seeking Alpha
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff 3:23 p.m. April 21, 2014 - Seeking Alpha
10-K: REXAHN PHARMACEUTICALS, INC. 3:21 p.m. March 21, 2014 - Edgar Online - (EDG = 10Q, 10K)
Phase I Data on Rexahn's Supinoxin - Analyst Blog 4:30 p.m. March 12, 2014 - Zacks.com
Rexahn Pharma up 10% 12:26 p.m. March 11, 2014 - Seeking Alpha
Rexahn cancer drug safe so far in Phase I study, shares jump 7:33 a.m. March 11, 2014 - Seeking Alpha
Loading more headlines...
Press Releases on RNN
Rexahn Pharmaceuticals Reports Third Quarter 2014 Financial Results and Pipeline Update 9:01 a.m. Nov. 13, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the Stifel 2014 Healthcare Conference on November 18, 2014 9:01 a.m. Nov. 11, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the BIO-Europe(R) Conference in Frankfurt, Germany 8:01 a.m. Oct. 28, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at 13th Annual BIO Investor Forum 8:00 a.m. Sept. 30, 2014 - GlobeNewswire
Market Movers - Biotech Stocks - Hemispherx Biopharma, Aegerion Pharma, Cytori Therapeutics, Alnylam Pharma, and Rexahn Pharma 8:00 a.m. Sept. 25, 2014 - PR Newswire - PRF
Rexahn Receives FDA Orphan Drug Designation for RX-3117 in Treatment of Pancreatic Cancer 3:31 p.m. Sept. 24, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the 14th Annual Biotech in Europe Investor Forum for Global Partnering and Investment in Basel, Switzerland 8:01 a.m. Sept. 23, 2014 - GlobeNewswire
Rexahn Pharmaceuticals to Present at the BioPharm America™ 2014 in Boston, Massachusetts, USA 8:02 a.m. Sept. 16, 2014 - BusinessWire - BZX
Rexahn Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference on September 9,2014 8:00 a.m. Sept. 4, 2014 - BusinessWire - BZX
Rexahn Receives a Notice of Allowance from the U.S. Patent and Trademark Office for a Novel Targeted Cancer Drug Delivery Platform 8:01 a.m. Sept. 3, 2014 - BusinessWire - BZX
Market Movers - Biotech Stocks -- Progenics Pharma, Rexahn Pharma, ImmunoGen, Hemispherx Biopharma, and Incyte 8:20 a.m. Aug. 21, 2014 - PR Newswire - PRF
Epigenetic R&D, Therapies and Diagnostics: Industry and Market Prospects 2014-2024 12:22 p.m. Aug. 19, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals Reports Second Quarter 2014 Financial Results and Pipeline Update 8:01 a.m. Aug. 14, 2014 - BusinessWire - BZX
Rexahn Pharmaceuticals Provides Update on Phase I Supinoxin Trial in Cancer Patients with Solid Tumors 8:01 a.m. July 18, 2014 - BusinessWire - BZX
Stocks Coverage on Biotech Equities -- Research on Gilead Sciences, ARIAD Pharma, Rexahn Pharma, and Geron 6:10 a.m. May 30, 2014 - PR Newswire - PRF
Three biotechs stocks with positive institutional transactions, good price to cash ratios and "buy" recommendations from street analysts 7:09 a.m. May 22, 2014 - ACCESSWIRE
Pharmaceutical Development & Medical Cannabis Expand at an Aggressive Rate - Company Attracts Major Attention at WebCongress Conference in San Francisco 8:20 a.m. May 16, 2014 - PR Newswire - PRF
Rexahn Pharmaceuticals Reports First Quarter 2014 Financial Results and Pipeline Update 8:03 a.m. May 15, 2014 - BusinessWire - BZX
Rexahn Announces Additional Data from Preclinical Studies of RX-3117 8:02 a.m. May 8, 2014 - BusinessWire - BZX
Biotech Stocks Review -- Research on Retrophin, Merrimack, Gilead Sciences, and Rexahn Pharma 11:37 a.m. May 6, 2014 - PR Newswire - PRF
Loading more headlines...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Humberto Quintanar Strengthens McKinley Irvin's Seattle Team

Updated Category News Views 46

Humberto Quintanar Makes His Move In a world where legal battles can shake lives to the core, McKinley Irvin is throwing another heavyweight into the ring. They’ve just pulled in Humberto Quintanar, a guy who knows his way around a courtroom like a cabbie knows a city's backstreets. This isn't just another seat-fillin' lawyer; Quintanar packs years of experience as a...

Continue Reading
Approved Oil Secures Long-Term NYC Fuel Terminal Deal

Updated Category News Views 94

Approved Oil Locks in Future with Sunoco Deal Amidst the contraction of New York City's fuel terminal landscape, securing a consistent lifeline to crucial infrastructure feels like striking gold. Approved Oil just locked down an agreement with Sunoco for a new terminal location that'll last deep into the 2040s, and it's about more than just securing a spot on the...

Continue Reading
Columbia Distributing Expands to Alaska: A Growth Move

Updated Category News Views 33

Alaska's Entry: Columbia's New Frontier When Columbia Distributing dives into a new territory, you know they're serious about growth. This latest move sees them planting their flag in Alaska, finally completing a strategic vision that's been brewing for a while. Four-State Strategy Comes to Fruition The transaction with Republic National Distributing Company (RNDC) is no...

Continue Reading
Gildan's Troubling Legal Struggles: Investor Action Alert

Updated Category News Views 60

Gildan's Bumpy Ride: Legal Woes Unfold Well, folks, seems like Gildan Activewear Inc. (NYSE:GIL) is in for a bumpy ride, and not the kind that makes you feel alive, I tell ya. They've been slapped with a class action lawsuit, and the news ain't pretty. Accusations are flying hot about how they've been playing fast and loose with their financials. The Allegations: Channel...

Continue Reading
DropGenie Nets $5M to Boost Functional Biology Reach

Updated Category News Views 109

DropGenie Scores Big with Fresh Financing Boost Out of the Montreal wilderness, DropGenie is charging forward with a fresh $5 million injection in Seed+ financing. This isn't just loose change; it's a ticket to accelerating their mission of advancing functional biology platforms and beefing up data partnerships. You know, the kind of partnerships that even the suits in...

Continue Reading
Skechers Facing Class Action: Investors Urged to Act

Updated Category News Views 0

Skechers Under Fire: Fraud Allegations Surface Alright, if you've been around the stock block a while, you know these stories can often read like a suspense novel. Plot twist: Skechers U.S.A., Inc. (formerly NYSE: SKX) is now facing some serious accusations. There's a class action lawsuit claiming that some shady dealings went down during the company's $9.4 billion...

Continue Reading
Cumberland Pharmaceuticals Eyes NDA for Ifetroban in DMD

Updated Category News Views 0

Rolling the Dice with Ifetroban There's a buzz in the air around Cumberland Pharmaceuticals as they gear up to tackle one of medicine's stubborn giants, Duchenne muscular dystrophy (DMD). They plan to file a New Drug Application (NDA) with the FDA for ifetroban, aiming to treat the cardiomyopathy plaguing many DMD sufferers. Folks who’ve watched Cumberland (NASDAQ:CPIX)...

Continue Reading
Ernesta Expands Southeast Reach with Atlanta Showroom

Updated Category News Views 85

Ernesta's Southeast Play: The Atlanta Showroom Here's something to turn heads in the world of custom home design—Ernesta has just set up shop in Atlanta, a move that speaks volumes about their ambitions in the Southeast market. This isn't just about selling a few more rugs; it's a calculated step into a region ripe with design potential and a hunger for bespoke home...

Continue Reading
Gildan Activewear Faces Major Class Action Lawsuit

Updated Category News Views 126

Investors Turn Against Gildan Activewear Ever see a freight train barreling down the track? That's what it feels like when a class action lawsuit rears its head against a behemoth like Gildan Activewear Inc. (NYSE: GIL). After years of allegedly pulling the wool over investors' eyes, those same investors are now being called to muster—their chance to lead a charge of...

Continue Reading
Bertram Capital Backs MCE's Expansive Growth Vision

Updated Category News Views 92

A Strategic Move for Bertram Capital Right on the heels of seasoned market moves, Bertram Capital has thrown its support behind Motion & Control Enterprises (MCE). This isn't just another portfolio addition; it's a calculated step into the complex world of industrial distribution, partnering with a company renowned for its prowess in engineered solutions. If you've ever...

Continue Reading

Top 5 Most Recently Viewed Articles

Discover Opportunities at the 2026 China Clean Expo

Updated Category News Views 158

Welcome to the China Clean Expo 2026 The 27th China Clean Expo (CCE) is set to take place from March 31 to April 3, 2026, at the Shanghai New International Expo Center. This event, organized by IM Sinoexpo with support from notable associations, including ISSA, promises to be a hub for industry leaders, innovators, and solution providers in the cleaning sector. The...

Continue Reading
Magellan Health and Calm Health Collaboration Enhances Support

Updated Category News Views 372

Magellan Health Partners with Calm Health Magellan Health, Inc. is excited to announce a new partnership with Calm Health, aimed at providing improved mental health support for its members. This collaboration is designed to streamline the process for individuals seeking help, ensuring they receive the necessary resources in a timely manner. Understanding the Importance of...

Continue Reading
Celebrating the Visionaries: 2025 Franklin Institute Laureates

Updated Category News Views 3874

Honoring Global Innovators Across Science and Business The Franklin Institute is set to celebrate the exceptional contributions of its 2025 Franklin Institute Laureates. This illustrious occasion recognizes pioneers who have made significant advancements in science, technology, and business leadership. Among the nine distinguished honorees are trailblazers like Muyinatu...

Continue Reading
Origin Investments Launches Innovative 1031 Exchange Program

Updated Category News Views 267

Origin Investments Enters the 1031 Exchange Market Origin Investments has marked a significant milestone by completing its first acquisition under the newly established Origin Exchange program, which focuses on Delaware Statutory Trust (DST) investments. The company has acquired The Starling, a modern multifamily community featuring 300 recently developed units,...

Continue Reading
Tenaris Sees Growth Amid Challenges in Q2 2025 Financials

Updated Category News Views 263

Tenaris Reports Second Quarter Financial Results for 2025 Tenaris S.A. (NYSE: TS, BMV: TS.MX, Milan: TEN) has released its financial results for the second quarter of 2025, demonstrating resilience in a fluctuating market. Compared to the same period last year, there have been notable changes in performance metrics, illustrating both growth opportunities and challenges...

Continue Reading